ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives. ALX Oncology’s lead ...

A scriverlo - sul suo X - è Elon Musk, commentando un post di Alx, che si presenta come “american ... Le leggi si decidono su X o in Parlamento?”. Il portavoce di Europa Verde Angelo Bonelli ...

ALX Oncology's lead therapeutic candidate, evorpacept, is a highly differentiated potential best- and first-in-class CD47 checkpoint inhibitor and one of the most advanced checkpoint inhibitors to ...

ALX Oncology’s phase 2 gastric cancer response rate has weakened. After seeing its CD47 blocker easily beat control over the first half of the trial, the biotech reported a much closer fight in ...

ALX Oncology, a Bay Area biotech firm currently running clinical trials for its anticancer therapy, announced Wednesday that it’s laying off about 30% of its staff. ALX shared the news in a ...

A copy of the poster presentation will be available on the Publications section of ALX Oncology’s website at the start of the presentation at SABCS on December 12, 2024.

Chief Medical Officer of ALX Oncology, Dr. Alan Sandler, underlined the design of the treatment, which combines anti-HER2 antibodies efficiently to improve results. For the second-line treatment ...

“Sarebbe un onore parlare con il presidente Mattarella” scrive Elon Musk in risposta a un post di un utente, dal nome ALX, che cita un articolo sullo stato delle relazioni fra il governo ...

ALX, Africa’s leading tech career accelerator, is celebrating a major win for young African talent as 21 exceptional learners from the ALX Pathway program secure prestigious scholarships from ...

The live webcast of the Jefferies fireside chat can be accessed by visiting the Investors section of ALX Oncology's website at www.alxoncology.com under the Events section of the Events and ...